Business and people search

Rosemont Pharmaceuticals acquired by US giant for £180m

David Parkin
David Parkin

YORKSHIRE-BASED pharmaceuticals manufacturer Rosemont has been sold by its private equity owner to a listed US group in a deal worth £180m.

The sees Leeds firm Rosemont Pharmaceuticals sold by CBPE Capital to Perrigo Company, a $10bn US group. Its management team will remain in place under the new owner.

CBPE acquired Rosemont in August 2006 for £93m. The sale to Perrigo represents an investment multiple of 3.25 times CBPE’s £52m equity investment over the investment period.

Rosemont d... for the full story register now for free or login below...

Login to Read this Story

Latest Business News

TheBusinessDesk is a trading name of Regional Media Services Ltd.
A company registered in the UK, company number : 07111349 VAT Number : 124302954